Skip to search form
Skip to main content
>
Semantic Scholar
Semantic Scholar's Logo
Search
Sign In
Create Free Account
You are currently offline. Some features of the site may not work correctly.
TL-118
Known as:
Antiangiogenic Drug Combination TL-118
A proprietary, oral suspension containing a combination of agents comprised of a nonsteroidal anti-inflammatory agent, an alkylating agent, a…
Expand
National Institutes of Health
Create Alert
Related topics
Related topics
5 relations
Broader (5)
Cimetidine
Cyclophosphamide
Diclofenac
Drug Combinations
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
TL-118 and Gemcitabine Drug Combination Display Therapeutic Efficacy in a MYCN Amplified Orthotopic Neuroblastoma Murine Model – Evaluation by MRI
Chani Komar-Stossel
,
E. Gross
,
+4 authors
R. Abramovitch
PloS one
2014
Corpus ID: 14751412
Neuroblastoma (NB) is the most common extra-cranial pediatric solid tumor with up to 50% of NB patients classified as having high…
Expand
2013
2013
TL-118—anti-angiogenic treatment in pancreatic cancer: a case report
Shani Breuer
,
Ofra Maimon
,
L. Appelbaum
,
T. Peretz
,
A. Hubert
Medical Oncology
2013
Corpus ID: 7145902
Pancreatic cancer is one of the most aggressive malignant tumors. In recent years, little progress has been made in understanding…
Expand
2012
2012
Improved efficacy of a novel anti-angiogenic drug combination (TL-118) against colorectal-cancer liver metastases; MRI monitoring in mice
Y. Edrei
,
E. Gross
,
N. Corchia
,
R. Abramovitch
British Journal of Cancer
2012
Corpus ID: 6701891
Background:The poor prognosis of patients with colorectal-cancer liver metastases (CRLM) and the insufficiency of available…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
,
Terms of Service
, and
Dataset License
ACCEPT & CONTINUE